WuXi AppTec Co., Ltd. (603259.SH) Latest Company News

Oct 29, 2026, 12:27 UTC
Active public funds increased their holdings of WuXi AppTec by 38.37% in the third quarter, from 206 million shares to 285 million shares.
Source:
- finance.sina.cn
Oct 26, 2026, 08:59 UTC
WuXi AppTec raised its 2026 full-year guidance, forecasting total revenue of RMB 61.0 billion to RMB 61.9 billion and 40% to 42% year-over-year growth in continuing-operations revenue.
Source:
- finance.sina.cn
- aastocks.com
Oct 26, 2026, 08:59 UTC
WuXi AppTec reported 2026 first-three-quarter revenue of RMB 45.537 billion, up 38.6% year over year, net profit attributable to shareholders of RMB 19.398 billion, up 60.64%, adjusted net profit of RMB 16.477 billion, up 73.03%, and continuing-operations orders on hand of RMB 76.740 billion at the end of September, up 36.4%.
Source:
Oct 16, 2026, 10:19 UTC
BlackRock, Inc. reduced its long position in WuXi AppTec’s Hong Kong-listed H shares from 6.43% to 5.10%.
Source:
- finance.sina.cn
- finance.sina.cn
Oct 15, 2026, 09:10 UTC
BlackRock, Inc. increased its holdings in WuXi AppTec H shares from 5.40% to 6.44%.
Source:
- finance.sina.cn
Oct 12, 2026, 08:43 UTC
WuXi AppTec said it will hold a board meeting on October 26, 2026, to review and approve the group’s third-quarter results for the nine months ended September 30, 2026, and related publication matters.
Source:
- finance.sina.cn
Oct 6, 2026, 08:12 UTC
Hong Kong stocks closed higher on October 6, 2026, with the Hang Seng Index up 240 points (1.0%) at 24,280, the Hang Seng Tech Index up 39 points (0.9%) at 4,223, and the China Enterprises Index up 77 points (1.0%) at 8,128 on turnover of HK$98.265 billion.
Source:
Oct 2, 2026, 04:12 UTC
Hong Kong stocks fell in the morning session on October 2, 2026, with the Hang Seng Index down 648 points (2.6%) to 23,964 and the Hang Seng Tech Index down 104 points (2.4%) to 4,149, while Central New Energy hit a record high, up 10.5%.
Source:
Sep 30, 2026, 09:47 UTC
On the last trading day before China's National Day holiday, Chinese pharmaceutical stocks surged broadly, with the pharma index closing up 2.73% and the innovative drug index up 3.42%, while semiconductors fell 2.75%.
Source:
- finance.ifeng.com
Sep 30, 2026, 09:46 UTC
WuXi AppTec stated on its interactive platform that it adheres to a 'HI (Human Intelligence) + AI' strategy to continuously improve service capabilities and operational efficiency for global clients.
Source:
- finance.sina.cn
Sep 30, 2026, 08:12 UTC
Hong Kong stocks closed higher on September 30, 2026, with the Hang Seng Index up 89 points or 0.4% at 24,613 and the Hang Seng Tech Index up 4 points or 0.1% at 4,253, on turnover of HK$187.158 billion.
Source:
Sep 23, 2026, 10:53 UTC
WuXi AppTec completed conversion of part of its RMB 6.78 billion zero-coupon USD-settled convertible bonds due 2027, issuing 1,207,001 new H shares at HK$153 per share on September 23, 2026.
Source:
- finance.sina.cn
Sep 21, 2026, 02:51 UTC
Hong Kong-listed innovative pharmaceutical stocks rose, with Akeso up 7.9% to HK$97.65, GenScript Biotech up 4.68% to HK$41.18, and other Chinese biopharma shares posting gains of over 7% to 9%.
Source:
- aastocks.com
Sep 21, 2026, 02:12 UTC
Hong Kong-listed biopharmaceutical stocks rallied broadly on September 21, with Shanghai Henlius Biotech up over 10%, Junshi Biosciences and Akeso up over 8%, Keymed Biosciences and InnoCare Pharma up over 7%, and RemeGen, GenScript Biotech, WuXi Biologics and Kelun-Biotech up over 6%.
Source:
- aastocks.com
Sep 11, 2026, 09:03 UTC
WuXi AppTec completed conversion of its RMB 6.78 billion zero-coupon convertible bonds due 2027, issuing 4,684,697 new H shares at HK$153 per share on September 11, 2026.
Source:
Sep 8, 2026, 08:37 UTC
WuXi AppTec converted its RMB 6.78 billion zero-coupon convertible bonds due 2027 into 6,321,703 new H shares on September 8, 2026.
Source:
Aug 27, 2026, 10:10 UTC
WuXi AppTec announced an interim A-share dividend of 5.10 yuan per 10 shares for the first half of 2026, totaling 1.256 billion yuan, with record date September 3, 2026 and payment date September 4, 2026.
Source:
- finance.sina.cn
Aug 24, 2026, 14:09 UTC
WuXi AppTec's DNA Encoded Library (DEL) platform suffered a cybersecurity incident; the company activated emergency response, hired external experts, and reported normal operations with no evidence of data misuse.
Source:
Aug 17, 2026, 09:06 UTC
BlackRock increased its long position in WuXi AppTec H-shares to 6.0% on August 12, 2026, from 5.94%, at an average price of HKD 198.87 per share.
Source:
- finance.sina.cn
Aug 9, 2026, 09:54 UTC
WuXi AppTec obtained approval from the U.S. District Court for the District of Columbia on August 7, 2026 for its preliminary injunction motion, prohibiting the U.S. Department of Defense from enforcing the 1260H designation, to avoid immediate adverse effects during judicial review.
Source:
Aug 4, 2026, 04:15 UTC
Blackstone is considering a fresh funding injection into Nvidia-backed AI coding firm Factory, likely valuing the company at over $3.5 billion.
Source:
- cityam.com
Aug 3, 2026, 11:54 UTC
WuXi AppTec announced on August 3, 2026 that it would start construction of the Changzhou new base ahead of schedule to accelerate global capacity expansion and meet surging customer demand.
Source:
- stock.jrj.com.cn
Aug 3, 2026, 10:00 UTC
WuXi AppTec announced a 2026 A-share employee stock ownership plan, granting up to 9.7012 million A-shares to no more than 4,000 management and core technical staff at a purchase price of 103.08 yuan per share, funded by a long-term incentive fund of up to 1 billion yuan.
Source:
- aastocks.com
- stock.jrj.com.cn
Aug 3, 2026, 09:47 UTC
WuXi AppTec released its 2026 interim report on August 3, reporting revenue of 28.897 billion yuan, up 38.93% year-on-year, and net profit attributable to shareholders of 11.08 billion yuan, up 29.43% year-on-year.
Source:
Jul 4, 2026, 11:52 UTC
Hong Kong-listed companies, led by Tencent Holdings, AIA Group, and Xiaomi Corporation, have conducted share buybacks totaling over 900 billion Hong Kong dollars year-to-date, with June 2026 reaching a monthly record of over 300 billion Hong Kong dollars.
Source:
- wap.eastmoney.com
- finance.sina.cn
Jul 3, 2026, 01:44 UTC
Nona Biosciences appointed Wang Peng as Chief Operating Officer, effective July 3.
Source:
- finance.sina.cn
Jul 2, 2026, 21:45 UTC
Alibaba and WuXi AppTec filed lawsuits challenging their designation on the Pentagon's 1260H List.
Source:
- theepochtimes.com
Jul 2, 2026, 21:45 UTC
The Pentagon published an updated 1260H List on June 8, 2025, adding Alibaba, BYD, WuXi AppTec, and Zhongji Innolight as Chinese military-linked companies.
Source:
- theepochtimes.com

603259.SH

Active public funds increased their holdings of WuXi AppTec by 38.37% in the third quarter, from 206 million shares to 285 million shares.

WuXi AppTec raised its 2026 full-year guidance, forecasting total revenue of RMB 61.0 billion to RMB 61.9 billion and 40% to 42% year-over-year growth in continuing-operations revenue.

BlackRock, Inc. reduced its long position in WuXi AppTec’s Hong Kong-listed H shares from 6.43% to 5.10%.

BlackRock, Inc. increased its holdings in WuXi AppTec H shares from 5.40% to 6.44%.

WuXi AppTec said it will hold a board meeting on October 26, 2026, to review and approve the group’s third-quarter results for the nine months ended September 30, 2026, and related publication matters.

Hong Kong stocks closed higher on October 6, 2026, with the Hang Seng Index up 240 points (1.0%) at 24,280, the Hang Seng Tech Index up 39 points (0.9%) at 4,223, and the China Enterprises Index up 77 points (1.0%) at 8,128 on turnover of HK$98.265 billion.

Hong Kong stocks fell in the morning session on October 2, 2026, with the Hang Seng Index down 648 points (2.6%) to 23,964 and the Hang Seng Tech Index down 104 points (2.4%) to 4,149, while Central New Energy hit a record high, up 10.5%.

On the last trading day before China's National Day holiday, Chinese pharmaceutical stocks surged broadly, with the pharma index closing up 2.73% and the innovative drug index up 3.42%, while semiconductors fell 2.75%.

WuXi AppTec stated on its interactive platform that it adheres to a 'HI (Human Intelligence) + AI' strategy to continuously improve service capabilities and operational efficiency for global clients.

Hong Kong stocks closed higher on September 30, 2026, with the Hang Seng Index up 89 points or 0.4% at 24,613 and the Hang Seng Tech Index up 4 points or 0.1% at 4,253, on turnover of HK$187.158 billion.

WuXi AppTec completed conversion of part of its RMB 6.78 billion zero-coupon USD-settled convertible bonds due 2027, issuing 1,207,001 new H shares at HK$153 per share on September 23, 2026.

Hong Kong-listed innovative pharmaceutical stocks rose, with Akeso up 7.9% to HK$97.65, GenScript Biotech up 4.68% to HK$41.18, and other Chinese biopharma shares posting gains of over 7% to 9%.

Hong Kong-listed biopharmaceutical stocks rallied broadly on September 21, with Shanghai Henlius Biotech up over 10%, Junshi Biosciences and Akeso up over 8%, Keymed Biosciences and InnoCare Pharma up over 7%, and RemeGen, GenScript Biotech, WuXi Biologics and Kelun-Biotech up over 6%.

WuXi AppTec completed conversion of its RMB 6.78 billion zero-coupon convertible bonds due 2027, issuing 4,684,697 new H shares at HK$153 per share on September 11, 2026.

WuXi AppTec converted its RMB 6.78 billion zero-coupon convertible bonds due 2027 into 6,321,703 new H shares on September 8, 2026.

WuXi AppTec announced an interim A-share dividend of 5.10 yuan per 10 shares for the first half of 2026, totaling 1.256 billion yuan, with record date September 3, 2026 and payment date September 4, 2026.

WuXi AppTec's DNA Encoded Library (DEL) platform suffered a cybersecurity incident; the company activated emergency response, hired external experts, and reported normal operations with no evidence of data misuse.

BlackRock increased its long position in WuXi AppTec H-shares to 6.0% on August 12, 2026, from 5.94%, at an average price of HKD 198.87 per share.

WuXi AppTec obtained approval from the U.S. District Court for the District of Columbia on August 7, 2026 for its preliminary injunction motion, prohibiting the U.S. Department of Defense from enforcing the 1260H designation, to avoid immediate adverse effects during judicial review.

Blackstone is considering a fresh funding injection into Nvidia-backed AI coding firm Factory, likely valuing the company at over $3.5 billion.

WuXi AppTec announced on August 3, 2026 that it would start construction of the Changzhou new base ahead of schedule to accelerate global capacity expansion and meet surging customer demand.

WuXi AppTec announced a 2026 A-share employee stock ownership plan, granting up to 9.7012 million A-shares to no more than 4,000 management and core technical staff at a purchase price of 103.08 yuan per share, funded by a long-term incentive fund of up to 1 billion yuan.

WuXi AppTec released its 2026 interim report on August 3, reporting revenue of 28.897 billion yuan, up 38.93% year-on-year, and net profit attributable to shareholders of 11.08 billion yuan, up 29.43% year-on-year.

Hong Kong-listed companies, led by Tencent Holdings, AIA Group, and Xiaomi Corporation, have conducted share buybacks totaling over 900 billion Hong Kong dollars year-to-date, with June 2026 reaching a monthly record of over 300 billion Hong Kong dollars.

Nona Biosciences appointed Wang Peng as Chief Operating Officer, effective July 3.

Alibaba and WuXi AppTec filed lawsuits challenging their designation on the Pentagon's 1260H List.

The Pentagon published an updated 1260H List on June 8, 2025, adding Alibaba, BYD, WuXi AppTec, and Zhongji Innolight as Chinese military-linked companies.